EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

Increased risk of hospitalization, intensive care and death due to COVID‐19 in patients with adrenal insufficiency: A Swedish nationwide study

Ragnhildur Bergthorsdottir iD, Daniela Esposito, Daniel S Olsson, Oskar Ragnarsson iD, Per Dahlqvist, Sophie Bensing, Jonatan Nåtman, Gudmundur Johannsson, Fredrik Nyberg

Journal of Internal Medicine · 2024

DOI: 10.1111/joim.13731 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Internal Medicine, 2024. Verfasst von Ragnhildur Bergthorsdottir und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Internal Medicine and Clinical Nutrition, Institute of Medicine, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden. Hauptthemen laut MEDLINE: COVID-19, Adrenal Insufficiency. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 33 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Patients with adrenal insufficiency (AI) have excess morbidity and mortality related to infectious disorders. Whether patients with AI have increased morbidity and mortality from COVID‐19 is unknown.

Methods

In this linked Swedish national register‐based cohort study, patients with primary and secondary AI diagnosis were identified and followed from 1 January 2020 to 28 February 2021. They were compared with a control cohort from the general population matched 10:1 for age and sex. The following COVID‐19 outcomes were studied: incidence of COVID‐19 infection, rates of hospitalization, intensive care admission and death. Hazard ratios (HR) with 95% confidence intervals (95% CI) adjusted for socioeconomic factors and comorbidities were estimated using Cox regression analysis.

Results

We identified 5430 patients with AI and 54,300 matched controls: There were 47.6% women, mean age was 57.1 (standard deviation 18.1) years, and the frequency of COVID‐19 infection was similar, but the frequency of hospitalization (2.1% vs. 0.8%), intensive care (0.3% vs. 0.1%) and death (0.8% vs. 0.2%) for COVID‐19 was higher in AI patients than matched controls. After adjustment for socioeconomic factors and comorbidities, the HR (95% CI) was increased for hospitalization (1.96, 1.59–2.43), intensive care admission (2.76, 1.49–5.09) and death (2.29, 1.60–3.28).

Conclusion

Patients with AI have a similar incidence of COVID‐19 infection to a matched control population, but a more than twofold increased risk of developing a severe infection or a fatal outcome. They should therefore be prioritized for vaccination, antiviral therapy and other appropriate treatment to mitigate hospitalization and death.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

COVID-19Adrenal InsufficiencyHumansFemaleMiddle AgedMaleCohort StudiesSwedenHospitalizationCritical Care

Stichwörter der Autor:innen

COVID-19adrenal insufficiencydeathglucocorticoidshospitalizationintensive care

Autor:innen und Institutionen

  • Department of Internal Medicine and Clinical Nutrition, Institute of Medicine, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden.
  • Department of Endocrinology, Sahlgrenska University Hospital, Gothenburg, Sweden.
  • Cardiovascular, Renal and Metabolism (CVRM), BioPharmaceuticals R&D, AstraZeneca, Gothenburg, Sweden.
  • Wallenberg Center for Molecular and Translational Medicine, University of Gothenburg, Gothenburg, Sweden.
  • Department of Public Health and Clinical Medicine, Umeå University, Umeå, Sweden.
  • Department of Molecular Medicine and Surgery, Karolinska Institutet, Stockholm, Sweden.

ORCID-Profile: Ragnhildur Bergthorsdottir, Oskar Ragnarsson

Zitieren

APA

Bergthorsdottir, R., Esposito, D., Olsson, D. S., Ragnarsson, O., Dahlqvist, P., Bensing, S., Nåtman, J., Johannsson, G., & Nyberg, F. (2024). Increased risk of hospitalization, intensive care and death due to COVID‐19 in patients with adrenal insufficiency: A Swedish nationwide study. Journal of Internal Medicine. https://doi.org/10.1111/joim.13731

Vancouver

Bergthorsdottir R, Esposito D, Olsson DS, Ragnarsson O, Dahlqvist P, Bensing S, et al. Increased risk of hospitalization, intensive care and death due to COVID‐19 in patients with adrenal insufficiency: A Swedish nationwide study. Journal of Internal Medicine. 2024. doi:10.1111/joim.13731

BibTeX
@article{Bergthorsdottir2024,
  author = {Bergthorsdottir, Ragnhildur and Esposito, Daniela and Olsson, Daniel S and Ragnarsson, Oskar and Dahlqvist, Per and Bensing, Sophie and Nåtman, Jonatan and Johannsson, Gudmundur and Nyberg, Fredrik},
  title = {Increased risk of hospitalization, intensive care and death due to COVID‐19 in patients with adrenal insufficiency: A Swedish nationwide study},
  journal = {Journal of Internal Medicine},
  year = {2024},
  doi = {10.1111/joim.13731}
}
Kostenlos starten →